Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the CAGR of the Antiemetics And Antinauseants Market Influence Its Overall Growth by 2034?

The size of the antiemetics and antinauseants market has been consistently increasing over recent years. It is projected to expand from a value of $8.11 billion in 2024 to $8.45 billion in 2025, signifying a compound annual growth rate (CAGR) of 4.3%. The observed growth during the historic period is the result of factors such as established branding and competitive market dynamics, traditional treatment preferences, the state of the economy, past global health incidents, and progress in medical research and development.

In the coming years, a steady growth trajectory is anticipated for the antiemetics and antinauseants market. The market is projected to escalate to $9.7 billion by 2029, with a compound annual growth rate (CAGR) of 3.5%. Factors contributing to the growth during the predicted period include research and development efforts, economical elements, market rivalry, industry trends, evolving disease patterns, and healthcare regulations and policies. Key trends for the forecast period encompass an enhanced emphasis on patient experiences, alterations in healthcare policies, a consumer inclination towards non-invasive treatments, an upsurge in chemotherapy and pregnancy-related nausea cases, and the arrival of targeted therapies.

What Strategic Factors Are Influencing the Accelerated Growth of the antiemetics and antinauseants Market?

The market for antiemetics and antinauseants is influenced by the growing incidence rate of cancer. As one of the most advised treatments for cancer, chemotherapy comes with side effects like chemotherapy-induced nausea and vomiting (CINV). Antiemetics have been shown to prevent CINV in around 60%-70% of patients. For instance, in April 2024, The American Cancer Society, a US-based NGO, projected approximately 609,000 deaths related to cancer and forecasted 1.9 million new cancer cases in the country in 2022. They further anticipate around 620,000 cancer deaths, signifying a slight increase in mortality rates in 2024. The rising occurrence of cancer will stimulate the demand for antiemetics and antinauseants, consequently increasing the market’s revenue.

Request Your Free Antiemetics And Antinauseants Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp

Who Are the Leading Companies Pioneering Change in the Antiemetics And Antinauseants Market?

Major companies operating in the antiemetics and antinauseants market include:

• Pfizer Inc._x000D_

• Johnson & Johnson Services Inc._x000D_

• Merck & Co. Inc._x000D_

• Bayer AG_x000D_

• Novartis AG_x000D_

What Are the Most Significant Trends Transforming the Antiemetics And Antinauseants Market Today?

Key players in the antinauseant and antiemetic markets are focusing on innovative product development, such as pre-prepared injectables, to simplify therapies and increase patient adherence. These ready-made formulations aim to offer instant relief, mitigating the time and intricacy involved with conventional injectable medications. For example, Amneal Pharmaceuticals, a speciality pharmaceutical business based in the US, introduced FOCINVEZ, the inaugural ready-to-use injectable version of fosaprepitant, in July 2024. This product is specifically created to control immediate and postponed nausea and vomiting linked with intense emetogenic cancer chemotherapy. It can be procured in a 150 mg/50 mL vial, without any Polysorbate 80, and no need for dilution or reconstitution, enabling direct administration. FOCINVEZ has been sanctioned for application in adults and children patients aged six months and above, and is recognized by a unique J-Code (J1434) for reimbursement purposes.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

How Are the Key Segments of the Antiemetics And Antinauseants Market Impacting Its Expansion and Revenue Streams?

The antiemetics and antinauseants market covered in this report is segmented –

1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types

2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types

3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

Subsegments:

1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone

2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant

3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine

4) By Cannabinoids: Dronabinol, Nabilone

5) By Benzodiazepines: Lorazepam, Diazepam

6) By Anticholinergics: Scopolamine, Glycopyrrolate

7) By Steroids: Dexamethasone, Methylprednisolone

8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron

9) By Other Drug Types: Herbal Remedies, Acupressure Devices

Which Regions Are Leading the Charge in Antiemetics And Antinauseants Market Development?

North America was the largest region in the drugs for antiemetics and antinauseants market in 2024. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Scope and Reach of the Antiemetics And Antinauseants Market Defined?

The antiemetics and antinauseants refer to drugs that are used in the prophylaxis or management of vomiting that results from emetogenic chemotherapy, and for the management of postoperative nausea and vomiting. Antiemetic and antinauseant drugs prevent, control, or treat, nausea and vomiting caused in general or by other medications, frequent motion sickness, infections, stomach flu, or chemotherapy. These drugs reduced the symptoms of nausea or vomiting by blocking signal messages to the part of the brain that controls nausea and vomiting.

Browse Through More Similar Reports By The Business Research Company:

Cough And Cold Preparations Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cough-and-cold-preparations-global-market-report

Smart Healthcare Products Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/smart-healthcare-products-global-market-report

Smart Pills Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/smart-pills-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: